Skip to main content

Table 1 Participants’ demographic and serology results

From: Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients

CategoryItemHCME/CFSp value
General demographicsAge (years)43.10 ± 4.08943.50 ± 4.1260.989
Gender> 0.999
 Male (%, n)(40%, 4)(40%, 4)
 Female (%, n)(60%, 6)(60%, 6)
BMI (kg/m2)23.41 ± 0.88125.21 ± 0.9370.120
WHODAS1.382 ± 0.51838.73 ± 5.504< 0.0001
 Illness demographics (SF-36)Pain (%)85.91 ± 5.02628.18 ± 7.971< 0.0001
Physical Functioning (%)98.64 ± 0.97535.45 ± 6.085< 0.0001
Role physical (%)97.15 ± 1.54713.08 ± 5.686< 0.0001
General Health (%)74.99 ± 4.17130.67 ± 3.988< 0.0001
Social functioning (%)95.45 ± 3.04928.41 ± 7.922< 0.0001
Emotional wellbeing (%)94.45 ± 3.04974.02 ± 9.2770.069
 Serology reportWBC5.945 ± 0.3716.909 ± 0.5390.223
Lymphocytes1.705 ± 0.1271.947 ± 0.1060.223
Neutrophils3.575 ± 0.2884.241 ± 0.5010.519
Monocytes0.466 ± 0.0510.502 ± 0.0510.467
Eosinophils0.150 ± 0.0310.518 ± 0.0510.935
Basophils0.046 ± 0.0050.048 ± 0.0060.955
Platelets252.8 ± 24.12246.8 ± 9.2130.797
RBC4.665 ± 0.1024.808 ± 0.1650.835
Haematocrit0.416 ± 0.0090.428 ± 0.0130.618
Haemoglobin136.2 ± 3.261142.9 ± 4.0890.339
  1. Data are represented as mean ± SEM using Mann Whitney U tests
  2. HC healthy controls, ME/CFS myalgic encephalomyelitis/chronic fatigue syndrome, BMI body mass index, RBC red blood cell, SF-36 short-form health survey, WBC white blood cell, WHODAS world health organisation disability assessment schedule
  3. *** p < 0.0001